The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients
N/A
9 Years
18 Years
9 Years
18 Years
Open (Enrolling)
Female
Chronic Kidney Disease, Dialysis
Female
Chronic Kidney Disease, Dialysis
Trial Information
The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients
Inclusion Criteria:
- 9-18-year-old girls who have CKD stages 3 or 4 (Glomerular filtration rates 15-59
mL/min/1.73m2).
- 9-18-year-old girls who are on dialysis.
- 9-18-year-old girls who have had a functioning kidney transplant for longer than 6
months and are on the same immunosuppression regimen.
- Healthy 9-18-year-old girls
Exclusion Criteria:
- Pregnancy, fever, allergy to any vaccine component, any immune disorder and any blood
product received in the previous 6 months.
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Principal Investigator
Corina Nailescu, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Indiana University/Riley Children's Hospital
Authority:
United States: Institutional Review Board
Study ID:
0807-02
NCT ID:
NCT00767897
Start Date:
November 2011
Completion Date:
November 2014
Related Keywords:
- Chronic Kidney Disease
- Dialysis
- Dose response relationship
- immunity
- Kidney Diseases
- Papilloma
- Renal Insufficiency, Chronic
- Kidney Failure, Chronic
Name | Location |
|---|---|
| Indiana University/Riley Children's Hospital | Indianapolis, Indiana 46202 |
